Additionally, LRRC25 was confirmed to play a protective role in primary lower-grade glioma (Zhang et al., 2020), and was shown to be significantly upregulated during neonatal hypoxic-ischemia neuronal damage in vitro (Xiong et al., 2020). The gene discussed is LRRC25; the disease is central nervous system cancer.